IL17A and rheumatoid arthritis: IL-17 treatment increased the expression of autophagy-specific markers such as LC3-I, LC3-II and ATG5 in RA FLSs, which also supports the idea that IL-17 plays a unique role in the differences between RA and OA (Figure 5).